| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1086033390 |
| P356 | DOI | 10.1038/CDDIS.2017.248 |
| P932 | PMC publication ID | 5520906 |
| P698 | PubMed publication ID | 28617438 |
| P50 | author | Ningbo Xu | Q57571770 |
| P2093 | author name string | Zhao Yang | |
| Boyang Liu | |||
| Hongbo Guo | |||
| Changlin Lian | |||
| Huijun Zeng | |||
| Zhao Fu | |||
| P2860 | cites work | CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells | Q54377230 |
| Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model | Q38739262 | ||
| Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition | Q38759750 | ||
| Ionizing radiation induces a motile phenotype in human carcinoma cells in vitro through hyperactivation of the TGF-beta signaling pathway | Q38846848 | ||
| Temozolomide competes for P-glycoprotein and contributes to chemoresistance in glioblastoma cells | Q38849643 | ||
| Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance | Q38937280 | ||
| Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. | Q38955683 | ||
| Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy | Q39017301 | ||
| CTGF increases drug resistance to paclitaxel by upregulating survivin expression in human osteosarcoma cells | Q39030787 | ||
| TGF-β: an emerging player in drug resistance | Q39105549 | ||
| Targeting of TGFβ signature and its essential component CTGF by miR-18 correlates with improved survival in glioblastoma. | Q39224420 | ||
| CTGF is overexpressed in malignant melanoma and promotes cell invasion and migration. | Q39524486 | ||
| Aldehyde dehydrogenase 1 positive glioblastoma cells show brain tumor stem cell capacity | Q39680687 | ||
| Connective tissue growth factor confers drug resistance in breast cancer through concomitant up-regulation of Bcl-xL and cIAP1. | Q39863143 | ||
| Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines | Q40252973 | ||
| Rapamycin increases CCN2 expression of lung fibroblasts via phosphoinositide 3-kinase | Q42479992 | ||
| Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas | Q44418604 | ||
| Transforming growth factor β induces expression of connective tissue growth factor in hepatic progenitor cells through Smad independent signaling | Q45852778 | ||
| Proposal for a unified CCN nomenclature | Q24535512 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Cancer stem cell metabolism: a potential target for cancer therapy | Q28079045 | ||
| Signal transduction by the TGF-beta superfamily | Q28201963 | ||
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial | Q29547224 | ||
| EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer | Q29616360 | ||
| Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features | Q29620020 | ||
| Non-Smad pathways in TGF-beta signaling | Q29620040 | ||
| The human Cyr61 gene is a transcriptional target of transforming growth factor beta in cancer cells | Q30440228 | ||
| Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme | Q34158700 | ||
| Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling. | Q34217241 | ||
| Cyr61 promotes epithelial-mesenchymal transition and tumor metastasis of osteosarcoma by Raf-1/MEK/ERK/Elk-1/TWIST-1 signaling pathway | Q34410089 | ||
| miR-125b controls apoptosis and temozolomide resistance by targeting TNFAIP3 and NKIRAS2 in glioblastomas | Q34423084 | ||
| Chemoresistance of glioblastoma cancer stem cells - much more complex than expected | Q35521316 | ||
| Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors | Q35545648 | ||
| TGF-β promotes heterogeneity and drug resistance in squamous cell carcinoma | Q35871985 | ||
| O6-methylguanine DNA methyltransferase as a promising target for the treatment of temozolomide-resistant gliomas | Q36288503 | ||
| Mechanisms of chemoresistance to alkylating agents in malignant glioma | Q36726010 | ||
| Cancer stem cells and chemoresistance: The smartest survives the raid | Q36730432 | ||
| The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence | Q36795940 | ||
| Regulation of CCN2 mRNA expression and promoter activity in activated hepatic stellate cells | Q36942777 | ||
| CCN2, the connective tissue growth factor | Q37031962 | ||
| Connective tissue growth factor (CTGF) and cancer progression | Q37214721 | ||
| Transforming growth factor-β (TGF-β)-mediated connective tissue growth factor (CTGF) expression in hepatic stellate cells requires Stat3 signaling activation | Q37234131 | ||
| Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines | Q37536715 | ||
| Current concepts and management of glioblastoma | Q37904921 | ||
| Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer | Q38212057 | ||
| Cellular and molecular actions of CCN2/CTGF and its role under physiological and pathological conditions | Q38258015 | ||
| Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. | Q38315365 | ||
| Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells | Q38558752 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 6 | |
| P921 | main subject | connective tissue | Q25615 |
| glioblastoma | Q282142 | ||
| P304 | page(s) | e2885 | |
| P577 | publication date | 2017-06-15 | |
| P1433 | published in | Cell Death and Disease | Q2197222 |
| P1476 | title | Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling | |
| P478 | volume | 8 |
| Q57788828 | Apatinib suppresses cell growth and metastasis and promotes antitumor activity of temozolomide in glioma |
| Q91251189 | CTGF regulates cyclic stretch-induced vascular smooth muscle cell proliferation via microRNA-19b-3p |
| Q64068632 | Celastrol mediates autophagy and apoptosis via the ROS/JNK and Akt/mTOR signaling pathways in glioma cells |
| Q92237966 | Cellular Senescence and the Kidney: Potential Therapeutic Targets and Tools |
| Q90515465 | Connective tissue growth factor as an unfavorable prognostic marker promotes the proliferation, migration, and invasion of gliomas |
| Q65000057 | ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer. |
| Q58797237 | Glycogenolysis in Acquired Glioma Resistance to Temozolomide: A Role for the [Ca]-dependent Activation of Na,K-ATPase/ERK Signaling |
| Q59136674 | Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma |
| Q59335925 | OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth |
| Q57816901 | The Role of the Extracellular Matrix and Its Molecular and Cellular Regulators in Cancer Cell Plasticity |
| Q91791041 | The TGFβ1-FOXM1-HMGA1-TGFβ1 positive feedback loop increases the cisplatin resistance of non-small cell lung cancer by inducing G6PD expression |
| Q92592813 | YAP/TAZ Signaling and Resistance to Cancer Therapy |
Search more.